Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion
Rhea-AI Summary
ADIA Nutrition Inc. (OTC Pink: ADIA) has launched a recruitment drive for sales representatives for its subsidiaries, Adia Med and Adia Labs. The initiative, announced on March 13, 2025, aims to expand the company's regenerative medicine and stem cell therapy presence nationwide.
Adia Med sales representatives will focus on establishing satellite locations by partnering with doctors, clinics, and medical spas, targeting regions with high demand for regenerative medicine. Meanwhile, Adia Labs representatives will promote 'Adia Vita,' a private-label umbilical cord stem cell product containing 100 million stem cells and 3 trillion exosomes per unit, for medical studies and research.
The company offers commission-based compensation and comprehensive training. Ideal candidates should possess strong communication skills, commitment to ethical practices, and knowledge or willingness to learn about regenerative medicine.
Positive
- Expansion initiative through nationwide recruitment of sales force
- Strategic focus on high-demand markets for regenerative medicine
- Innovative product offering with Adia Vita containing significant stem cell count
Negative
- Commission-based compensation structure indicates variable income potential
- Success dependent on building new partnerships and market penetration
News Market Reaction – ADIA
In the trading session that priced this news, ADIA declined 2.89%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Unleashing the Future of Stem Cell Therapy and Regenerative Medicine Across the U.S.
Winter Park, Florida--(Newsfile Corp. - March 13, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in health, wellness, and regenerative medicine, is thrilled to announce it is recruiting dynamic sales representatives for its subsidiaries, Adia Med and Adia Labs, with job postings now live on Indeed. This bold initiative, a key part of ADIA Nutrition's roadmap for success and profitability, will propel the company's mission to deliver cutting-edge stem cell therapies and regenerative solutions to doctors, clinics, and medical spas nationwide by securing top-tier sales talent.
Adia Med Sales Representatives
Adia Nutrition is seeking motivated sales professionals to join Adia Med, tasked with partnering with doctors, clinics, and leading medical spas to establish Adia Med satellite locations. These reps will research target demographics and high-opportunity regions, pinpointing cities with strong demand for regenerative medicine. Within their region, they'll collaborate with top med spas, physicians, and clinics to structure deals that integrate Adia Med's innovative therapies, enhancing patient care and broadening the subsidiary's national presence.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/243941_adia_med_sales_indeed.jpg
Ideal candidates for Adia Med sales representatives should possess strong communication and networking skills, a commitment to ethical practices in sales, and an understanding-or willingness to learn-about regenerative medicine and stem cell therapies.
Adia Labs Sales Representatives
At the same time, Adia Nutrition is building an exceptional sales team for Adia Labs to promote its flagship stem cell product, "Adia Vita." These representatives will connect with doctors and clinics within their region, offering Adia Vita-a private-label umbilical cord stem cell product packed with 100 million stem cells and 3 trillion exosomes per unit-for studies, trials, and research. This team will drive Adia Labs' efforts to push the boundaries of medical science.
"We're looking for a passionate, skilled sales force to take our vision nationwide," said Larry Powalisz, CEO of Adia Nutrition. "We aim to empower our sales team with the knowledge and tools to make a real difference in people's lives. This isn't just a sales job; it's a chance to be part of a movement toward more effective, patient-centered healthcare."
Ideal candidates for Adia Labs sales reps should bring a background in medical or health-related sales, strong communication and networking skills, a commitment to ethical practices in healthcare sales, and an understanding-or eagerness to learn-about regenerative medicine and stem cell therapies.
Adia Nutrition offers commission-based compensation, comprehensive training, and the opportunity to lead the charge in an expanding field of medicine.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/243941_adia_labs_sales_rep_indeed.jpg
To Apply, visit https://www.indeed.com/cmp/Adia-Nutrition/jobs or you can contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243941